Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» stroke
stroke
DiaMedica prepares to end 10-month FDA hold on late-phase stroke trial by halving dose
DiaMedica prepares to end 10-month FDA hold on late-phase stroke trial by halving dose
Fierce Biotech
DiaMedica Therapeutics
FDA
clinical trials
stroke
Flag link:
Busy with 3 program launches this year, Biogen trims pipeline
Busy with 3 program launches this year, Biogen trims pipeline
Fierce Biotech
Biogen
stroke
gene therapy
ophthalmology
earnings
Flag link:
Shionogi starts global Phase II clinical trial of redasemtide
Shionogi starts global Phase II clinical trial of redasemtide
Clinical Trials Arena
Shionogi
clinical trials
redasemtide
stroke
Flag link:
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
clinical trials
Bristol Myers Squibb
JNJ
milvexian
stroke
Flag link:
FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial
FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial
Clinical Trials Arena
Pharmazz
sovateltide
stroke
cerebral ischemia
FDA
Flag link:
FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study
FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study
Endpoints
Pfizer
bivalent boosters
vaccines
COVID-19
stroke
Flag link:
U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke
U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke
Yahoo/Reuters
FDA
CDC
Pfizer
BioNTech
bivalent boosters
vaccines
COVID-19
elderly
stroke
Flag link:
Influenza vaccination reduces the risk of stroke
Influenza vaccination reduces the risk of stroke
Clinical Trials Arena
flu vaccines
vaccines
stroke
Flag link:
Medtronic Teases Collaboration Platform for Stroke Innovation
Medtronic Teases Collaboration Platform for Stroke Innovation
Medical Devices and Diagnostics Industry
Medtronic
devices
Medtech
stroke
incubators
Flag link:
Penumbra’s catheters achieve first-pass revascularization in 68.9% of stroke patients
Penumbra’s catheters achieve first-pass revascularization in 68.9% of stroke patients
Medtech Dive
Medtech
devices
Penumbra
RED reperfusion catheters
ischemic stroke
stroke
revascularization
Flag link:
Boston Scientific touts early results of real-world Watchman FLX study
Boston Scientific touts early results of real-world Watchman FLX study
Medtech Dive
devices
Boston Scientific
Watchman FLX
real world data
real world evidence
stroke
atrial fibrillation
Flag link:
Vagal nerve stimulator for stroke rehab nabs FDA nod
Vagal nerve stimulator for stroke rehab nabs FDA nod
RAPS.org
vagal nerve stimulation
stroke
chronic ischemic stroke
FDA
devices
MicroTransponder
Flag link:
Could These 3 Potential Blockbusters Transform Biogen?
Could These 3 Potential Blockbusters Transform Biogen?
Motley Fool
Biogen
zuranolone
depression
TMS-007
stroke
Aduhelm
Alzheimer's disease
Flag link:
Boston Scientific's Watchman shows low stroke rate in large registry at ACC
Boston Scientific's Watchman shows low stroke rate in large registry at ACC
Medtech Dive
Boston Scientific
devices
WATCHMAN
ACC
stroke
atrial fibrillation
Flag link:
Biogen buys midphase drug to challenge Roche for stroke market
Biogen buys midphase drug to challenge Roche for stroke market
Fierce Biotech
Biogen
acute ischemic stroke
stroke
TMS
Flag link:
FDA greenlights device to retrain muscles in stroke patients
FDA greenlights device to retrain muscles in stroke patients
Medtech Dive
Neurolutions
devices
stroke
FDA
Flag link:
AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup
AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup
Pharma Times
AstraZeneca
clinical trials
Brilinta
stroke
Flag link:
Go or no go? Vaccine panel upstages US approval decisions
Go or no go? Vaccine panel upstages US approval decisions
EP Vantage
FDA
vaccines
COVID-19
advisory panel
Eysuvis
Brilinta
Kala Pharmaceuticals
dry eye disease
Regeneron
AstraZeneca
stroke
Flag link:
AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients
AstraZeneca's Brilinta looks for label boost with trial win, priority review in stroke patients
Fierce Pharma
Brilinta
AstraZeneca
stroke
clinical trials
Flag link:
Tamping down stroke damage with a drug that protects brain cells
Tamping down stroke damage with a drug that protects brain cells
Fierce Biotech
TAT-DP-2
stroke
University of Pittsburgh
Flag link:
Pages
1
2
3
4
5
6
next ›
last »